FOI/2025/26/145

Request

I am writing to you under the Freedom of Information Act 2000 to request the following information from Central London Community Healthcare NHS Trust. Please may you provide me with the information for the following:

 

1. Testing and Management Protocols for Carbapenem-Resistant Enterobacteriaceae (CRE)

 

1.1. Does your trust have a clinical protocol for testing and managing patients for Carbapenem-Resistant Enterobacteriaceae (CRE)?

    If yes:    a) Is your CRE testing protocol primarily molecular-based?    b) If not, please specify which type of testing protocol is followed.

 

3.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for CRE from?

 

No, we do not have a clinical testing protocol for this as we do not run a laboratory.  If risk assessment identified the need to screen a patient for CRE, samples would be processed by the agreed local acute laboratory and this would be done following their protocols. 

 

Any patient identified would be managed as per the Trust isolation policy which is aligned to the NHSE National Infection Prevention Manual and UKHSA guidance.

 

2. Testing Protocols for Clostridioides difficile (C. difficile) Infection

 

2.1. Does your trust have a formal protocol for testing patients for Clostridioides difficile (C. difficile) infection?

  If yes:  a) Is your C. difficile testing protocol molecular-based?  b) If not, please specify the testing method used.

 

3.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for C. difficile from?

 

No, we do not have a clinical testing protocol for this as we do not run a laboratory.  If clinical and risk assessment identified the need to screen a patient for C. difficile, samples would be processed by the agreed local acute laboratory and this would be done following their protocols. 

 

Any patient identified would be managed as per the Trust isolation policy which is aligned to the NHSE National Infection Prevention Manual and UKHSA guidance.

 

3. Testing and Procurement for Tuberculosis (TB) Resistance

 

3.1. What methods does your trust use to test for tuberculosis (TB) resistance?3.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for TB resistance from?

 

Not applicable as we do not have a laboratory.